Cite

    David Gelmont et al.. “Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long‐term, placebo‐controlled study of Alzheimer's disease.” Alzheimer's & dementia, vol. 2, no. 2, 2016, pp. 131–139. http://access.bl.uk/ark:/81055/vdc_100102661431.0x000004